N/A
Manufactured by A.P. Deauville, LLC
16 FDA adverse event reports analyzed
Last updated: 2026-04-15
ALUMINUM SESQUICHLOROHYDRATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by A.P. Deauville, LLC. The most commonly reported adverse reactions for ALUMINUM SESQUICHLOROHYDRATE include ADMINISTRATION SITE PAIN, APPLICATION SITE ERYTHEMA, APPLICATION SITE PAIN, BURNING SENSATION, CHEMICAL BURN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ALUMINUM SESQUICHLOROHYDRATE.
Out of 6 classified reports for ALUMINUM SESQUICHLOROHYDRATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 16 FDA FAERS reports that mention ALUMINUM SESQUICHLOROHYDRATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ADMINISTRATION SITE PAIN, APPLICATION SITE ERYTHEMA, APPLICATION SITE PAIN, BURNING SENSATION, CHEMICAL BURN, CYST. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list A.P. Deauville, LLC in connection with ALUMINUM SESQUICHLOROHYDRATE. Always verify the specific product and NDC with your pharmacist.